Cg Oncology Inc. (CGON) Company Profile & Statistics

Cg Oncology Inc.
CGON
(Nasdaq - US)
Open
33.42
+0.53 (+1.60%)
in:usd•As of: Nov 18, 2024 12:14 UTC -5
Open
33.39
High
33.84
Low
32.55

About Cg Oncology Inc.

CEO

Arthur Kuan

Headquarters

400 spectrum center drive, suite 2040

irvine, ca 92618, united states

Auditor

Ernst & Young LLP

Employees

Share Holders

111

Website

https://cgoncology.com

Industry

biotechnology

Sector

health technology

Company Overview

CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. CG Oncology is based in IRVINE, Calif.

Cg Oncology Inc. Statistics

Valuation Measures

Market Capitalization ²	2.26B
Enterprise Value	2.22B
Enterprise Value/EBITDA (ttm)	-21.39
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	4.11
Price to Sales (ttm)	3.25K
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	75.00%
Operating Margin (ttm)	-10642.98%
Profit Margin (ttm)	-16920.77%
Return on Equity (ttm)	-18.97%
Return on Invested Capital (ttm)	3.25%
Return on Assets (ttm)	-15.36%

Income Statement

Revenue (ttm)	684.00K
Revenue Per Share (ttm)	0.01
Gross Profit (ttm)	684.00K
EBITDA (ttm)³	-103.64M
Net Income Avi to Common (ttm)	-78.73M
Diluted EPS (ttm)	N/A

Share Statistics

Beta (5Y Monthly)	N/A
52-Week Change	N/A
S&P500 52-Week Change	29.59%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	67.63M
Dividend Yield	0.00%
Float ⁴	0.00
% Held by Insiders	N/A
% Held by Institutions	26.56%

Balance Sheet

Total Cash (mrq)	540.71M
Total Cash Per Share (mrq)	8.00
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	35.32%
Quick Ratio (mrq)	35.32%
Book Value Per Share (mrq)	7.95

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.86
Free Cash Flow (ytd)	-58.08M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Cg Oncology Inc.

Trade With A Regulated Broker